-
Mashup Score: 25Evolution, and current and future role of radiotherapy in the treatment of haematological malignancies - 1 year(s) ago
Haematological malignancies are generally highly radiosensitive. Radiotherapy for these diseases was introduced shortly after the discovery of x-rays, and early development happened in a setting where such therapy was the only effective, and possibly curative, treatment method. Advances in technology in the 1950s and 1960s led to very extensive treatment fields, planned with the crude two-dimensional techniques available, to doses of 36–40 Gy or even higher. With the sparse knowledge of the underlying biology of these diseases, roughly the same principles were used in all patients.
Source: www.thelancet.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 21
Combination treatment of low-dose, single-fraction radiotherapy with pembrolizumab was safe, with early promise of response activity. Our approach could be an option for patients with relapsed or refractory multiple myeloma who have not responded to previous treatment. Larger trials to substantiate our findings are needed.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 32The development of academic CAR T cells - 1 year(s) ago
Chimeric antigen receptor (CAR) T cells have transformed the way that multiple haematological malignancies are managed. In the EU, six products manufactured by four marketing authorisation holders (MAHs) are currently approved for 14 indications (appendix pp 1–2). The availability of these products has undoubtedly improved the prospects of many patients with these diseases, but it has also created substantial inequalities due to lack of access within the EU and across the globe.
Source: www.thelancet.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 1UK tainted blood: amplifying the voices of the victims - 1 year(s) ago
On May 20, 2024, the final report on the UK Infected Blood Inquiry was finally published. The inquiry was set up in 2017, after years of campaigning by the victims and families who received contaminated blood in the 1970s and 1980s, leaving up to 30 000 people infected with hepatitis and HIV. According to the report, more than 3000 preventable deaths so far are attributable to infected blood and blood products, which make this scandal the largest disaster in the history of the National Health Service (NHS).
Source: www.thelancet.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 54
Explore the current issue of The Lancet Haematology, a monthly journal dedicated to publishing content that advocates change in, or illuminates, haematological clinical practice
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Epcoritamab monotherapy showed clinically meaningful activity in patients with multiply relapsed or refractory follicular lymphoma, and had a manageable safety profile.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 8Improving outcomes in sickle cell disease - 1 year(s) ago
Commissioners Dr Michael R DeBaun and Dr Dipty Jain, and Lwimba Kasongo, MPH, who has lived experience of sickle cell disease, outline some of the obstacles …
Source: www.youtube.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Our findings show a strikingly high contribution of sickle cell disease to all-cause mortality that is not apparent when each death is assigned to only a single cause. Sickle cell disease mortality burden is highest in children, especially in countries with the greatest under-5 mortality rates. Without comprehensive strategies to address morbidity and mortality associated with sickle cell disease, attainment of SDG 3.1, 3.2, and 3.4 is uncertain. Widespread data gaps and correspondingly high uncertainty in the estimates highlight the urgent need for routine and sustained surveillance efforts, further research to assess the contribution of conditions associated with sickle cell disease, and widespread deployment of evidence-based prevention and treatment for those with sickle cell disease.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Epcoritamab monotherapy showed clinically meaningful activity in patients with multiply relapsed or refractory follicular lymphoma, and had a manageable safety profile.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3
Epcoritamab monotherapy showed clinically meaningful activity in patients with multiply relapsed or refractory follicular lymphoma, and had a manageable safety profile.
Source: www.thelancet.comCategories: General Medicine News, Onc News and JournalsTweet
"Modern radiotherapy... is a highly varied and individualised treatment, based on advanced imaging, sophisticated treatment techniques, and an understanding of the biological diversity" @LenaSpecht1 on #radiotherapy in #hemonc in this special issue🧵⬇️ https://t.co/ajHHA1q1dB